Global Vulvar and Vaginal Atrophy Therapy Market Insights, Forecast to 2030

1 Study Coverage
1.1 Vulvar and Vaginal Atrophy Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Vulvar Atrophy Therapy
1.2.3 Vaginal Atrophy Therapy
1.3 Market by Application
1.3.1 Global Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Vulvar and Vaginal Atrophy Therapy Sales Estimates and Forecasts 2019-2030
2.2 Global Vulvar and Vaginal Atrophy Therapy Revenue by Region
2.2.1 Global Vulvar and Vaginal Atrophy Therapy Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Vulvar and Vaginal Atrophy Therapy Revenue by Region (2019-2024)
2.2.3 Global Vulvar and Vaginal Atrophy Therapy Revenue by Region (2025-2030)
2.2.4 Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Region (2019-2030)
2.3 Global Vulvar and Vaginal Atrophy Therapy Sales Estimates and Forecasts 2019-2030
2.4 Global Vulvar and Vaginal Atrophy Therapy Sales by Region
2.4.1 Global Vulvar and Vaginal Atrophy Therapy Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Vulvar and Vaginal Atrophy Therapy Sales by Region (2019-2024)
2.4.3 Global Vulvar and Vaginal Atrophy Therapy Sales by Region (2025-2030)
2.4.4 Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Vulvar and Vaginal Atrophy Therapy Sales by Manufacturers
3.1.1 Global Vulvar and Vaginal Atrophy Therapy Sales by Manufacturers (2019-2024)
3.1.2 Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vulvar and Vaginal Atrophy Therapy in 2023
3.2 Global Vulvar and Vaginal Atrophy Therapy Revenue by Manufacturers
3.2.1 Global Vulvar and Vaginal Atrophy Therapy Revenue by Manufacturers (2019-2024)
3.2.2 Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Vulvar and Vaginal Atrophy Therapy Revenue in 2023
3.3 Global Key Players of Vulvar and Vaginal Atrophy Therapy, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Vulvar and Vaginal Atrophy Therapy Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Vulvar and Vaginal Atrophy Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Vulvar and Vaginal Atrophy Therapy, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Vulvar and Vaginal Atrophy Therapy, Product Offered and Application
3.8 Global Key Manufacturers of Vulvar and Vaginal Atrophy Therapy, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vulvar and Vaginal Atrophy Therapy Sales by Type
4.1.1 Global Vulvar and Vaginal Atrophy Therapy Historical Sales by Type (2019-2024)
4.1.2 Global Vulvar and Vaginal Atrophy Therapy Forecasted Sales by Type (2025-2030)
4.1.3 Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type (2019-2030)
4.2 Global Vulvar and Vaginal Atrophy Therapy Revenue by Type
4.2.1 Global Vulvar and Vaginal Atrophy Therapy Historical Revenue by Type (2019-2024)
4.2.2 Global Vulvar and Vaginal Atrophy Therapy Forecasted Revenue by Type (2025-2030)
4.2.3 Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Type (2019-2030)
4.3 Global Vulvar and Vaginal Atrophy Therapy Price by Type
4.3.1 Global Vulvar and Vaginal Atrophy Therapy Price by Type (2019-2024)
4.3.2 Global Vulvar and Vaginal Atrophy Therapy Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Vulvar and Vaginal Atrophy Therapy Sales by Application
5.1.1 Global Vulvar and Vaginal Atrophy Therapy Historical Sales by Application (2019-2024)
5.1.2 Global Vulvar and Vaginal Atrophy Therapy Forecasted Sales by Application (2025-2030)
5.1.3 Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2019-2030)
5.2 Global Vulvar and Vaginal Atrophy Therapy Revenue by Application
5.2.1 Global Vulvar and Vaginal Atrophy Therapy Historical Revenue by Application (2019-2024)
5.2.2 Global Vulvar and Vaginal Atrophy Therapy Forecasted Revenue by Application (2025-2030)
5.2.3 Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Application (2019-2030)
5.3 Global Vulvar and Vaginal Atrophy Therapy Price by Application
5.3.1 Global Vulvar and Vaginal Atrophy Therapy Price by Application (2019-2024)
5.3.2 Global Vulvar and Vaginal Atrophy Therapy Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Vulvar and Vaginal Atrophy Therapy Market Size by Type
6.1.1 US & Canada Vulvar and Vaginal Atrophy Therapy Sales by Type (2019-2030)
6.1.2 US & Canada Vulvar and Vaginal Atrophy Therapy Revenue by Type (2019-2030)
6.2 US & Canada Vulvar and Vaginal Atrophy Therapy Market Size by Application
6.2.1 US & Canada Vulvar and Vaginal Atrophy Therapy Sales by Application (2019-2030)
6.2.2 US & Canada Vulvar and Vaginal Atrophy Therapy Revenue by Application (2019-2030)
6.3 US & Canada Vulvar and Vaginal Atrophy Therapy Market Size by Country
6.3.1 US & Canada Vulvar and Vaginal Atrophy Therapy Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Vulvar and Vaginal Atrophy Therapy Sales by Country (2019-2030)
6.3.3 US & Canada Vulvar and Vaginal Atrophy Therapy Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Vulvar and Vaginal Atrophy Therapy Market Size by Type
7.1.1 Europe Vulvar and Vaginal Atrophy Therapy Sales by Type (2019-2030)
7.1.2 Europe Vulvar and Vaginal Atrophy Therapy Revenue by Type (2019-2030)
7.2 Europe Vulvar and Vaginal Atrophy Therapy Market Size by Application
7.2.1 Europe Vulvar and Vaginal Atrophy Therapy Sales by Application (2019-2030)
7.2.2 Europe Vulvar and Vaginal Atrophy Therapy Revenue by Application (2019-2030)
7.3 Europe Vulvar and Vaginal Atrophy Therapy Market Size by Country
7.3.1 Europe Vulvar and Vaginal Atrophy Therapy Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Vulvar and Vaginal Atrophy Therapy Sales by Country (2019-2030)
7.3.3 Europe Vulvar and Vaginal Atrophy Therapy Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Vulvar and Vaginal Atrophy Therapy Market Size
8.1.1 China Vulvar and Vaginal Atrophy Therapy Sales (2019-2030)
8.1.2 China Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030)
8.2 China Vulvar and Vaginal Atrophy Therapy Market Size by Application
8.2.1 China Vulvar and Vaginal Atrophy Therapy Sales by Application (2019-2030)
8.2.2 China Vulvar and Vaginal Atrophy Therapy Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Vulvar and Vaginal Atrophy Therapy Market Size by Type
9.1.1 Asia Vulvar and Vaginal Atrophy Therapy Sales by Type (2019-2030)
9.1.2 Asia Vulvar and Vaginal Atrophy Therapy Revenue by Type (2019-2030)
9.2 Asia Vulvar and Vaginal Atrophy Therapy Market Size by Application
9.2.1 Asia Vulvar and Vaginal Atrophy Therapy Sales by Application (2019-2030)
9.2.2 Asia Vulvar and Vaginal Atrophy Therapy Revenue by Application (2019-2030)
9.3 Asia Vulvar and Vaginal Atrophy Therapy Sales by Region
9.3.1 Asia Vulvar and Vaginal Atrophy Therapy Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Vulvar and Vaginal Atrophy Therapy Revenue by Region (2019-2030)
9.3.3 Asia Vulvar and Vaginal Atrophy Therapy Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Market Size by Type
10.1.1 Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Market Size by Application
10.2.1 Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Sales by Country
10.3.1 Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Almirall
11.1.1 Almirall Company Information
11.1.2 Almirall Overview
11.1.3 Almirall Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Almirall Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Almirall Recent Developments
11.2 VenusConcept
11.2.1 VenusConcept Company Information
11.2.2 VenusConcept Overview
11.2.3 VenusConcept Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 VenusConcept Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 VenusConcept Recent Developments
11.3 Alma Lasers
11.3.1 Alma Lasers Company Information
11.3.2 Alma Lasers Overview
11.3.3 Alma Lasers Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Alma Lasers Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Alma Lasers Recent Developments
11.4 ThermiGen LLC
11.4.1 ThermiGen LLC Company Information
11.4.2 ThermiGen LLC Overview
11.4.3 ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 ThermiGen LLC Recent Developments
11.5 Lutronic
11.5.1 Lutronic Company Information
11.5.2 Lutronic Overview
11.5.3 Lutronic Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Lutronic Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lutronic Recent Developments
11.6 BTL Group of Companies
11.6.1 BTL Group of Companies Company Information
11.6.2 BTL Group of Companies Overview
11.6.3 BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BTL Group of Companies Recent Developments
11.7 Viveve
11.7.1 Viveve Company Information
11.7.2 Viveve Overview
11.7.3 Viveve Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Viveve Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Viveve Recent Developments
11.8 Fotona
11.8.1 Fotona Company Information
11.8.2 Fotona Overview
11.8.3 Fotona Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Fotona Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Fotona Recent Developments
11.9 Hologic
11.9.1 Hologic Company Information
11.9.2 Hologic Overview
11.9.3 Hologic Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Hologic Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hologic Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vulvar and Vaginal Atrophy Therapy Industry Chain Analysis
12.2 Vulvar and Vaginal Atrophy Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vulvar and Vaginal Atrophy Therapy Production Mode & Process
12.4 Vulvar and Vaginal Atrophy Therapy Sales and Marketing
12.4.1 Vulvar and Vaginal Atrophy Therapy Sales Channels
12.4.2 Vulvar and Vaginal Atrophy Therapy Distributors
12.5 Vulvar and Vaginal Atrophy Therapy Customers
13 Market Dynamics
13.1 Vulvar and Vaginal Atrophy Therapy Industry Trends
13.2 Vulvar and Vaginal Atrophy Therapy Market Drivers
13.3 Vulvar and Vaginal Atrophy Therapy Market Challenges
13.4 Vulvar and Vaginal Atrophy Therapy Market Restraints
14 Key Findings in The Global Vulvar and Vaginal Atrophy Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Vulvar Atrophy Therapy
Table 3. Major Manufacturers of Vaginal Atrophy Therapy
Table 4. Global Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Vulvar and Vaginal Atrophy Therapy Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Vulvar and Vaginal Atrophy Therapy Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Vulvar and Vaginal Atrophy Therapy Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Region (2019-2024)
Table 9. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Region (2025-2030)
Table 10. Global Vulvar and Vaginal Atrophy Therapy Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Vulvar and Vaginal Atrophy Therapy Sales by Region (2019-2024) & (K Units)
Table 12. Global Vulvar and Vaginal Atrophy Therapy Sales by Region (2025-2030) & (K Units)
Table 13. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Region (2019-2024)
Table 14. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Region (2025-2030)
Table 15. Global Vulvar and Vaginal Atrophy Therapy Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Vulvar and Vaginal Atrophy Therapy Sales Share by Manufacturers (2019-2024)
Table 17. Global Vulvar and Vaginal Atrophy Therapy Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Vulvar and Vaginal Atrophy Therapy Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Vulvar and Vaginal Atrophy Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Vulvar and Vaginal Atrophy Therapy Price by Manufacturers 2019-2024 (USD/Unit)
Table 21. Global Vulvar and Vaginal Atrophy Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Vulvar and Vaginal Atrophy Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vulvar and Vaginal Atrophy Therapy as of 2023)
Table 23. Global Key Manufacturers of Vulvar and Vaginal Atrophy Therapy, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Vulvar and Vaginal Atrophy Therapy, Product Offered and Application
Table 25. Global Key Manufacturers of Vulvar and Vaginal Atrophy Therapy, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Vulvar and Vaginal Atrophy Therapy Sales by Type (2019-2024) & (K Units)
Table 28. Global Vulvar and Vaginal Atrophy Therapy Sales by Type (2025-2030) & (K Units)
Table 29. Global Vulvar and Vaginal Atrophy Therapy Sales Share by Type (2019-2024)
Table 30. Global Vulvar and Vaginal Atrophy Therapy Sales Share by Type (2025-2030)
Table 31. Global Vulvar and Vaginal Atrophy Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Vulvar and Vaginal Atrophy Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Vulvar and Vaginal Atrophy Therapy Revenue Share by Type (2019-2024)
Table 34. Global Vulvar and Vaginal Atrophy Therapy Revenue Share by Type (2025-2030)
Table 35. Vulvar and Vaginal Atrophy Therapy Price by Type (2019-2024) & (USD/Unit)
Table 36. Global Vulvar and Vaginal Atrophy Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 37. Global Vulvar and Vaginal Atrophy Therapy Sales by Application (2019-2024) & (K Units)
Table 38. Global Vulvar and Vaginal Atrophy Therapy Sales by Application (2025-2030) & (K Units)
Table 39. Global Vulvar and Vaginal Atrophy Therapy Sales Share by Application (2019-2024)
Table 40. Global Vulvar and Vaginal Atrophy Therapy Sales Share by Application (2025-2030)
Table 41. Global Vulvar and Vaginal Atrophy Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Vulvar and Vaginal Atrophy Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Vulvar and Vaginal Atrophy Therapy Revenue Share by Application (2019-2024)
Table 44. Global Vulvar and Vaginal Atrophy Therapy Revenue Share by Application (2025-2030)
Table 45. Vulvar and Vaginal Atrophy Therapy Price by Application (2019-2024) & (USD/Unit)
Table 46. Global Vulvar and Vaginal Atrophy Therapy Price Forecast by Application (2025-2030) & (USD/Unit)
Table 47. US & Canada Vulvar and Vaginal Atrophy Therapy Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Vulvar and Vaginal Atrophy Therapy Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Vulvar and Vaginal Atrophy Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Vulvar and Vaginal Atrophy Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Vulvar and Vaginal Atrophy Therapy Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Vulvar and Vaginal Atrophy Therapy Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Vulvar and Vaginal Atrophy Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Vulvar and Vaginal Atrophy Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Vulvar and Vaginal Atrophy Therapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Vulvar and Vaginal Atrophy Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Vulvar and Vaginal Atrophy Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Vulvar and Vaginal Atrophy Therapy Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Vulvar and Vaginal Atrophy Therapy Sales by Country (2025-2030) & (K Units)
Table 60. Europe Vulvar and Vaginal Atrophy Therapy Sales by Type (2019-2024) & (K Units)
Table 61. Europe Vulvar and Vaginal Atrophy Therapy Sales by Type (2025-2030) & (K Units)
Table 62. Europe Vulvar and Vaginal Atrophy Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Vulvar and Vaginal Atrophy Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Vulvar and Vaginal Atrophy Therapy Sales by Application (2019-2024) & (K Units)
Table 65. Europe Vulvar and Vaginal Atrophy Therapy Sales by Application (2025-2030) & (K Units)
Table 66. Europe Vulvar and Vaginal Atrophy Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Vulvar and Vaginal Atrophy Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Vulvar and Vaginal Atrophy Therapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Vulvar and Vaginal Atrophy Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Vulvar and Vaginal Atrophy Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Vulvar and Vaginal Atrophy Therapy Sales by Country (2019-2024) & (K Units)
Table 72. Europe Vulvar and Vaginal Atrophy Therapy Sales by Country (2025-2030) & (K Units)
Table 73. China Vulvar and Vaginal Atrophy Therapy Sales by Type (2019-2024) & (K Units)
Table 74. China Vulvar and Vaginal Atrophy Therapy Sales by Type (2025-2030) & (K Units)
Table 75. China Vulvar and Vaginal Atrophy Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Vulvar and Vaginal Atrophy Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Vulvar and Vaginal Atrophy Therapy Sales by Application (2019-2024) & (K Units)
Table 78. China Vulvar and Vaginal Atrophy Therapy Sales by Application (2025-2030) & (K Units)
Table 79. China Vulvar and Vaginal Atrophy Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Vulvar and Vaginal Atrophy Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Vulvar and Vaginal Atrophy Therapy Sales by Type (2019-2024) & (K Units)
Table 82. Asia Vulvar and Vaginal Atrophy Therapy Sales by Type (2025-2030) & (K Units)
Table 83. Asia Vulvar and Vaginal Atrophy Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Vulvar and Vaginal Atrophy Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Vulvar and Vaginal Atrophy Therapy Sales by Application (2019-2024) & (K Units)
Table 86. Asia Vulvar and Vaginal Atrophy Therapy Sales by Application (2025-2030) & (K Units)
Table 87. Asia Vulvar and Vaginal Atrophy Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Vulvar and Vaginal Atrophy Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Vulvar and Vaginal Atrophy Therapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Vulvar and Vaginal Atrophy Therapy Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Vulvar and Vaginal Atrophy Therapy Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Vulvar and Vaginal Atrophy Therapy Sales by Region (2019-2024) & (K Units)
Table 93. Asia Vulvar and Vaginal Atrophy Therapy Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Sales by Country (2025-2030) & (K Units)
Table 107. Almirall Company Information
Table 108. Almirall Description and Major Businesses
Table 109. Almirall Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Almirall Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Almirall Recent Developments
Table 112. VenusConcept Company Information
Table 113. VenusConcept Description and Major Businesses
Table 114. VenusConcept Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. VenusConcept Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. VenusConcept Recent Developments
Table 117. Alma Lasers Company Information
Table 118. Alma Lasers Description and Major Businesses
Table 119. Alma Lasers Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Alma Lasers Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Alma Lasers Recent Developments
Table 122. ThermiGen LLC Company Information
Table 123. ThermiGen LLC Description and Major Businesses
Table 124. ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. ThermiGen LLC Recent Developments
Table 127. Lutronic Company Information
Table 128. Lutronic Description and Major Businesses
Table 129. Lutronic Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Lutronic Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Lutronic Recent Developments
Table 132. BTL Group of Companies Company Information
Table 133. BTL Group of Companies Description and Major Businesses
Table 134. BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. BTL Group of Companies Recent Developments
Table 137. Viveve Company Information
Table 138. Viveve Description and Major Businesses
Table 139. Viveve Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. Viveve Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Viveve Recent Developments
Table 142. Fotona Company Information
Table 143. Fotona Description and Major Businesses
Table 144. Fotona Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. Fotona Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Fotona Recent Developments
Table 147. Hologic Company Information
Table 148. Hologic Description and Major Businesses
Table 149. Hologic Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 150. Hologic Vulvar and Vaginal Atrophy Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Hologic Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Vulvar and Vaginal Atrophy Therapy Distributors List
Table 155. Vulvar and Vaginal Atrophy Therapy Customers List
Table 156. Vulvar and Vaginal Atrophy Therapy Market Trends
Table 157. Vulvar and Vaginal Atrophy Therapy Market Drivers
Table 158. Vulvar and Vaginal Atrophy Therapy Market Challenges
Table 159. Vulvar and Vaginal Atrophy Therapy Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Vulvar and Vaginal Atrophy Therapy Product Picture
Figure 2. Global Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Vulvar and Vaginal Atrophy Therapy Market Share by Type in 2023 & 2030
Figure 4. Vulvar Atrophy Therapy Product Picture
Figure 5. Vaginal Atrophy Therapy Product Picture
Figure 6. Global Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Vulvar and Vaginal Atrophy Therapy Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. Ambulatory Surgical Centers
Figure 10. Specialty Clinics
Figure 11. Others
Figure 12. Vulvar and Vaginal Atrophy Therapy Report Years Considered
Figure 13. Global Vulvar and Vaginal Atrophy Therapy Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Vulvar and Vaginal Atrophy Therapy Revenue 2019-2030 (US$ Million)
Figure 15. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Region (2019-2030)
Figure 17. Global Vulvar and Vaginal Atrophy Therapy Sales 2019-2030 ((K Units)
Figure 18. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Vulvar and Vaginal Atrophy Therapy Sales YoY (2019-2030) & (K Units)
Figure 20. US & Canada Vulvar and Vaginal Atrophy Therapy Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Vulvar and Vaginal Atrophy Therapy Sales YoY (2019-2030) & (K Units)
Figure 22. Europe Vulvar and Vaginal Atrophy Therapy Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Vulvar and Vaginal Atrophy Therapy Sales YoY (2019-2030) & (K Units)
Figure 24. China Vulvar and Vaginal Atrophy Therapy Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Vulvar and Vaginal Atrophy Therapy Sales YoY (2019-2030) & (K Units)
Figure 26. Asia (excluding China) Vulvar and Vaginal Atrophy Therapy Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Sales YoY (2019-2030) & (K Units)
Figure 28. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Vulvar and Vaginal Atrophy Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Vulvar and Vaginal Atrophy Therapy in the World: Market Share by Vulvar and Vaginal Atrophy Therapy Revenue in 2023
Figure 31. Global Vulvar and Vaginal Atrophy Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type (2019-2030)
Figure 33. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Type (2019-2030)
Figure 34. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2019-2030)
Figure 35. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Vulvar and Vaginal Atrophy Therapy Revenue Share by Country (2019-2030)
Figure 41. US & Canada Vulvar and Vaginal Atrophy Therapy Sales Share by Country (2019-2030)
Figure 42. U.S. Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type (2019-2030)
Figure 45. Europe Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Type (2019-2030)
Figure 46. Europe Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2019-2030)
Figure 47. Europe Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Application (2019-2030)
Figure 48. Europe Vulvar and Vaginal Atrophy Therapy Revenue Share by Country (2019-2030)
Figure 49. Europe Vulvar and Vaginal Atrophy Therapy Sales Share by Country (2019-2030)
Figure 50. Germany Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 51. France Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 55. China Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type (2019-2030)
Figure 56. China Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Type (2019-2030)
Figure 57. China Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2019-2030)
Figure 58. China Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Application (2019-2030)
Figure 59. Asia Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type (2019-2030)
Figure 60. Asia Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Type (2019-2030)
Figure 61. Asia Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2019-2030)
Figure 62. Asia Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Application (2019-2030)
Figure 63. Asia Vulvar and Vaginal Atrophy Therapy Revenue Share by Region (2019-2030)
Figure 64. Asia Vulvar and Vaginal Atrophy Therapy Sales Share by Region (2019-2030)
Figure 65. Japan Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 69. India Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Vulvar and Vaginal Atrophy Therapy Sales Share by Country (2019-2030)
Figure 76. Brazil Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Vulvar and Vaginal Atrophy Therapy Revenue (2019-2030) & (US$ Million)
Figure 81. Vulvar and Vaginal Atrophy Therapy Value Chain
Figure 82. Vulvar and Vaginal Atrophy Therapy Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit